Literature DB >> 30040234

Generation of Human Induced Pluripotent Stem Cells Using a Defined, Feeder-Free Reprogramming System.

Seonmi Park1, Gustavo Mostoslavsky1.   

Abstract

Human induced pluripotent stem cells (hiPSCs) offer great opportunities for the study of human development and disease modeling and have enormous potential for use in future clinical cell-based therapies. However, most current systems to create hiPSCs often expose the cells to animal feeder layers or xenogeneic reagents; this raises safety concerns about using hiPSC-derived cells for therapeutic purposes. Here, we describe protocols to generate hiPSCs without exposing the cells to xenogeneic materials that uses a defined, feeder-free reprogramming system. With this method, we were able to successfully reprogram not only patient-derived peripheral blood mononuclear cells but also amniocytes from the amniotic fluid of stillborn fetuses using two independent reprogramming platforms. Importantly, hiPSCs generated in this fashion expressed pluripotent markers and had normal karyotypes. The protocols allowed us to generate and culture hiPSCs under Good Manufacturing Practice-like conditions, a necessary step for the future clinical application of these cells. © 2018 by John Wiley & Sons, Inc.
Copyright © 2018 John Wiley & Sons, Inc.

Entities:  

Keywords:  STEMCCA lentiviral vector; Sendai virus vector; amniocytes; feeder-free reprogramming system; human induced pluripotent stem cells (hiPSCs); peripheral blood mononuclear cells (PBMCs)

Mesh:

Year:  2018        PMID: 30040234      PMCID: PMC6060628          DOI: 10.1002/cpsc.48

Source DB:  PubMed          Journal:  Curr Protoc Stem Cell Biol        ISSN: 1938-8969


  22 in total

1.  Isolation and production of cells suitable for human therapy: challenges ahead.

Authors:  Lars Ahrlund-Richter; Michele De Luca; Daniel R Marshak; Megan Munsie; Anna Veiga; Mahendra Rao
Journal:  Cell Stem Cell       Date:  2008-12-08       Impact factor: 24.633

2.  Reprogramming of human peripheral blood cells to induced pluripotent stem cells.

Authors:  Judith Staerk; Meelad M Dawlaty; Qing Gao; Dorothea Maetzel; Jacob Hanna; Cesar A Sommer; Gustavo Mostoslavsky; Rudolf Jaenisch
Journal:  Cell Stem Cell       Date:  2010-07-02       Impact factor: 24.633

3.  Induced pluripotent stem cells generated without viral integration.

Authors:  Matthias Stadtfeld; Masaki Nagaya; Jochen Utikal; Gordon Weir; Konrad Hochedlinger
Journal:  Science       Date:  2008-09-25       Impact factor: 47.728

4.  Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

Authors:  Kazutoshi Takahashi; Koji Tanabe; Mari Ohnuki; Megumi Narita; Tomoko Ichisaka; Kiichiro Tomoda; Shinya Yamanaka
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

5.  Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes.

Authors:  Trond Aasen; Angel Raya; Maria J Barrero; Elena Garreta; Antonella Consiglio; Federico Gonzalez; Rita Vassena; Josipa Bilić; Vladimir Pekarik; Gustavo Tiscornia; Michael Edel; Stéphanie Boué; Juan Carlos Izpisúa Belmonte
Journal:  Nat Biotechnol       Date:  2008-10-17       Impact factor: 54.908

6.  Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins.

Authors:  Dohoon Kim; Chun-Hyung Kim; Jung-Il Moon; Young-Gie Chung; Mi-Yoon Chang; Baek-Soo Han; Sanghyeok Ko; Eungi Yang; Kwang Yul Cha; Robert Lanza; Kwang-Soo Kim
Journal:  Cell Stem Cell       Date:  2009-05-28       Impact factor: 24.633

Review 7.  Pluripotent stem cells in disease modelling and drug discovery.

Authors:  Yishai Avior; Ido Sagi; Nissim Benvenisty
Journal:  Nat Rev Mol Cell Biol       Date:  2016-01-28       Impact factor: 94.444

8.  Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.

Authors:  Luigi Warren; Philip D Manos; Tim Ahfeldt; Yuin-Han Loh; Hu Li; Frank Lau; Wataru Ebina; Pankaj K Mandal; Zachary D Smith; Alexander Meissner; George Q Daley; Andrew S Brack; James J Collins; Chad Cowan; Thorsten M Schlaeger; Derrick J Rossi
Journal:  Cell Stem Cell       Date:  2010-09-30       Impact factor: 24.633

9.  Reprogramming of pancreatic beta cells into induced pluripotent stem cells.

Authors:  Matthias Stadtfeld; Kristen Brennand; Konrad Hochedlinger
Journal:  Curr Biol       Date:  2008-05-22       Impact factor: 10.834

10.  piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells.

Authors:  Knut Woltjen; Iacovos P Michael; Paria Mohseni; Ridham Desai; Maria Mileikovsky; Riikka Hämäläinen; Rebecca Cowling; Wei Wang; Pentao Liu; Marina Gertsenstein; Keisuke Kaji; Hoon-Ki Sung; Andras Nagy
Journal:  Nature       Date:  2009-03-01       Impact factor: 49.962

View more
  5 in total

1.  Preventive pharmacological treatment in subjects at risk for fatal familial insomnia: science and public engagement.

Authors:  Gianluigi Forloni; Ignazio Roiter; Vladimiro Artuso; Manuel Marcon; Walter Colesso; Elviana Luban; Ugo Lucca; Mauro Tettamanti; Elisabetta Pupillo; Veronica Redaelli; Francesco Mariuzzo; Giulia Boscolo Buleghin; Alice Mariuzzo; Fabrizio Tagliavini; Roberto Chiesa; Anna Ambrosini
Journal:  Prion       Date:  2022-12       Impact factor: 2.547

2.  Xeno-Free Reprogramming of Peripheral Blood Mononuclear Erythroblasts on Laminin-521.

Authors:  Christian Skorik; Nathaniel K Mullin; Michael Shi; Yosra Zhang; Phoebe Hunter; Yang Tang; Brianna Hilton; Thorsten M Schlaeger
Journal:  Curr Protoc Stem Cell Biol       Date:  2020-03

3.  Expression of HIV-1 Intron-Containing RNA in Microglia Induces Inflammatory Responses.

Authors:  Hisashi Akiyama; Sallieu Jalloh; Seonmi Park; Maohua Lei; Gustavo Mostoslavsky; Suryaram Gummuluru
Journal:  J Virol       Date:  2020-12-09       Impact factor: 5.103

4.  Tips and tricks for successfully culturing and adapting human induced pluripotent stem cells.

Authors:  Rocío Castro-Viñuelas; Clara Sanjurjo-Rodríguez; María Piñeiro-Ramil; Silvia Rodríguez-Fernández; Isidoro López-Baltar; Isaac Fuentes-Boquete; Francisco J Blanco; Silvia Díaz-Prado
Journal:  Mol Ther Methods Clin Dev       Date:  2021-11-03       Impact factor: 6.698

Review 5.  Manufacturing clinical-grade human induced pluripotent stem cell-derived beta cells for diabetes treatment.

Authors:  Lay Shuen Tan; Juin Ting Chen; Lillian Yuxian Lim; Adrian Kee Keong Teo
Journal:  Cell Prolif       Date:  2022-04-26       Impact factor: 8.755

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.